Market Place
Sourcing Support
Medexus Provides Update on Treosulfan NDA Resubmission Provides Business Update
19 Sep 2022 //
GLOBENEWSWIRE
Medexus Pharma Resubmits Treosulfan NDA To FDA
26 Jul 2022 //
NASDAQ
Treosulfan Pivotal Study Results Published
06 Jun 2022 //
GLOBENEWSWIRE
Medexus Strengthens Medical Affairs Team
10 Jun 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.